Vimarsana
Biggest News Aggregation in the World

Eric Camino News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Camino. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Camino Today - Breaking & Trending Today

Parent Project Muscular Dystrophy Provides $500,000 in Funding to Kinea Bio Through PPMD Venture Pathways Program to Support Next-Gen Midi-Dystrophin Gene Therapy Development - Vimarsana News

Parent Project Muscular Dystrophy Provides $500,000 in Funding to Kinea Bio Through PPMD Venture Pathways Program to Support Next-Gen Midi-Dystrophin Gene Therapy Development

/PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is excited...

Parent Project Muscular Dystrophy Provides $250,000 in Funding to Rare Disease Research, LLC to Establish New Clinical Trial Site - Vimarsana News

Parent Project Muscular Dystrophy Provides $250,000 in Funding to Rare Disease Research, LLC to Establish New Clinical Trial Site

/PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today...

CureDuchenne, Muscular Dystrophy Association, and Parent - Vimarsana News

CureDuchenne, Muscular Dystrophy Association, and Parent

New York, June 15, 2023 (GLOBE NEWSWIRE) -- June 15, 2023 -- CureDuchenne, Muscular Dystrophy Association (MDA), and Parent Project Muscular Dystrophy...

The Patient Experience Using MRI in DMD Clinical Trials — "Shed light through MRI", Upcoming Webinar Hosted by Xtalks - Vimarsana News

The Patient Experience Using MRI in DMD Clinical Trials — "Shed light through MRI", Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) March 31, 2022 -- Successful incorporation of imaging into a clinical trial requires careful consideration of the patient population and

Source: prweb.com
Parent Project Muscular Dystrophy Awards $31,500 Grant to Understand Immune Response to CRISPR/Cas-9 Gene Editing Strategies - Vimarsana News

Parent Project Muscular Dystrophy Awards $31,500 Grant to Understand Immune Response to CRISPR/Cas-9 Gene Editing Strategies

Share this article Share this article HACKENSACK, N.J., April 8, 2021 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), awarded the University of Missouri School of Medicine a bridge grant for $31,500 to continue evaluating CRISPR therapy in a pre-clinical model of Duchenne. The project is led by Dongsheng Duan, PhD, Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. Duchenne is the most common fatal genetic disorder diagnosed in childhood, affecting approximat...